Regulus Therapeutics Inc. Insider Trading for September 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Regulus Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Regulus Therapeutics Inc. for September 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 26 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.04 | 2,500 | 17,598 | 6,042,250 | 6 M to 6 M (-0.04 %) |
| Sep 26 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.12 | 2,500 | 17,790 | 6,044,750 | 6 M to 6 M (-0.04 %) |
| Sep 26 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.19 | 3,750 | 26,978 | 6,047,250 | 6.1 M to 6 M (-0.06 %) |
| Sep 26 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.04 | 2,500 | 17,598 | 6,941,250 | 6.9 M to 6.9 M (-0.04 %) |
| Sep 26 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.12 | 2,500 | 17,790 | 6,943,750 | 6.9 M to 6.9 M (-0.04 %) |
| Sep 26 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.19 | 3,750 | 26,978 | 6,946,250 | 7 M to 6.9 M (-0.05 %) |
| Sep 19 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.22 | 4,100 | 29,587 | 6,950,000 | 7 M to 7 M (-0.06 %) |
| Sep 19 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.40 | 1,500 | 11,098 | 6,954,100 | 7 M to 7 M (-0.02 %) |
| Sep 19 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.43 | 2,100 | 15,610 | 6,955,600 | 7 M to 7 M (-0.03 %) |
| Sep 19 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.22 | 4,100 | 29,587 | 6,051,000 | 6.1 M to 6.1 M (-0.07 %) |
| Sep 19 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.40 | 1,500 | 11,098 | 6,055,100 | 6.1 M to 6.1 M (-0.02 %) |
| Sep 19 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.43 | 2,100 | 15,610 | 6,056,600 | 6.1 M to 6.1 M (-0.03 %) |
| Sep 15 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,200 | 3,828 | 119,800 | |
| Sep 15 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Option Exercise | M | 1.74 | 2,000 | 3,480 | 122,000 | |
| Sep 15 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.01 | 2,200 | 17,617 | 80,000 | 82.2 K to 80 K (-2.68 %) |
| Sep 15 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,200 | 3,828 | 82,200 | 80 K to 82.2 K (+2.75 %) |
| Sep 15 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Sell | S | 8.01 | 2,000 | 16,010 | 80,000 | 82 K to 80 K (-2.44 %) |
| Sep 15 2014 | RGLS | Regulus Therapeuti ... | Gibson Neil W | Chief Scientific Of ... | Buy | M | 1.74 | 2,000 | 3,480 | 82,000 | 80 K to 82 K (+2.50 %) |
| Sep 12 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.96 | 3,500 | 27,861 | 6,957,700 | 7 M to 7 M (-0.05 %) |
| Sep 12 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.83 | 3,400 | 26,636 | 6,961,200 | 7 M to 7 M (-0.05 %) |
| Sep 12 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.70 | 2,000 | 15,399 | 6,964,600 | 7 M to 7 M (-0.03 %) |
| Sep 12 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.96 | 3,500 | 27,861 | 6,058,700 | 6.1 M to 6.1 M (-0.06 %) |
| Sep 12 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.83 | 3,400 | 26,636 | 6,062,200 | 6.1 M to 6.1 M (-0.06 %) |
| Sep 12 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.70 | 2,000 | 15,399 | 6,065,600 | 6.1 M to 6.1 M (-0.03 %) |
| Sep 05 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.07 | 2,400 | 16,974 | 6,067,600 | 6.1 M to 6.1 M (-0.04 %) |
| Sep 05 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 7.11 | 6,000 | 42,656 | 6,070,000 | 6.1 M to 6.1 M (-0.10 %) |
| Sep 05 2014 | RGLS | Regulus Therapeuti ... | ALNYLAM PHARMACEUTICALS, INC. | 10% Owner | Sell | S | 6.95 | 1,650 | 11,471 | 6,076,000 | 6.1 M to 6.1 M (-0.03 %) |
| Sep 05 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.07 | 2,400 | 16,974 | 6,966,600 | 7 M to 7 M (-0.03 %) |
| Sep 05 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 7.11 | 6,000 | 42,656 | 6,969,000 | 7 M to 7 M (-0.09 %) |
| Sep 05 2014 | RGLS | Regulus Therapeuti ... | ISIS PHARMACEUTICALS INC | Director | Sell | S | 6.95 | 1,650 | 11,471 | 6,975,000 | 7 M to 7 M (-0.02 %) |